Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Oral cyclosporin doesn't stop hair loss.

New medications could improve treatment for severe alopecia areata in Australia.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

A rare scalp condition with hair loss was correctly diagnosed and treated, leading to hair regrowth.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Alopecia areata is more common in young Black African males, with rare other health issues.